(S)-Bleximenib (oxalate)
Product Specifications
UNSPSC Description
(S)-Bleximenib ((S)-Menin-MLL inhibitor 24) oxalate is a S-Enantiomer of (S)-Menin-MLL inhibitor 24 oxalate (HY-148669A). (S)-Bleximenib oxalate is a menin-mixed-lineage leukemia 1 (menin-MLL) inhibitor, and can be used for the research of cancer[1].
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-bleximenib-oxalate.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COCCN(C)CCC[C@H](N1CC2(C1)CN(C3=NC=NN=C3OC4=C(C=C(C=C4)F)C(N(CC)C(C)C)=O)CC2)C(C)C.O=C(O)C(O)=O
Molecular Weight
689.82
References & Citations
[1]DASKALAKIS N, et, al. Combination therapies. WO2022237720A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148669B/S-Bleximenib-oxalate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148669B/S-Bleximenib-oxalate-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E21-RA32-1 2019-nCoV-Recombinant-Protein-Antigen
Recombinant 2019-nCoV S Protein RBD (C-mFc)(Mammalian expression)
Ask
View Details 
